Assess effects of edaravone combined with batroxobin in treatment of progressive cerebral infarction pa-tients
HU Yong-tao, Cheng Li
Abstract
HU Yong-tao, Cheng Li
Abstract
Objective To observe the efficacy of edaravone combined with batroxobin for progressive cerebral infarction.Methods The study was performed on progressive cerebral infarction patients(80cases),enrolled within 48 hour of onset.They were randomly divided into treatment group(40patients)and control group(40patients).The treatment group was allocated edaravone and batroxobin,and control group was allocated batroxobin.And then to observe the improvement of neurological function and the change of the fibrinogen in the blood.Results After three weeks,the apparent rate of the treatment group was 85%,higher than that of the control group 72.5%(P0.05).After two treatments the fibrinogen cut down dramatically(both P0.01).Conclusion Edaravone combined with batroxobin is an effective and safe therapy method for treating progressive cerebral infarction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the efficacy of edaravone combined with batroxobin for progressive cerebral infarction.Methods The study was performed on progressive cerebral infarction patients(80cases),enrolled within 48 hour of onset.They were randomly divided into treatment group(40patients)and control group(40patients).The treatment group was allocated edaravone and batroxobin,and control group was allocated batroxobin.And then to observe the improvement of neurological function and the change of the fibrinogen in the blood.Results After three weeks,the apparent rate of the treatment group was 85%,higher than that of the control group 72.5%(P0.05).After two treatments the fibrinogen cut down dramatically(both P0.01).Conclusion Edaravone combined with batroxobin is an effective and safe therapy method for treating progressive cerebral infarction.
Key concepts: Batroxobin, Edaravone, Medicine, Cerebral infarction, Fibrinogen, Anesthesia, Surgery, Internal medicine